Search | IOVS | ARVO Journals

Showing 1 – 20 of 28

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2025

OCT-derived tissue scatterer density and ganglion-cell-related layer thicknesses to assess physiological aging and glaucomatous changes

Thitiya Seesan; Shuichi Makita; Masahiro Miura; Atsuya Miki; Kosei Yanagida; Hidetaka Noma; Yoshiaki Yasuno

Invest. Ophthalmol. Vis. Sci.. 2025; 66(8):4245.

Retina December 2024

Changes in Aqueous Angiopoietin-1/2 Concentrations During the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular Edema

PDF

Masahiko Shimura; Shotaro Sasaki; Ryota Nonaka; Ikumi Kashiwagi; Kanako Yasuda; Hidetaka Noma; Hitoshi Takagi
TAGS: angiopoietins, cytokine, diabetic macular edema, faricimab, injections, vascular endothelial growth factor a
Trans. Vis. Sci. Tech.. 2024; 13(12):35. https://doi.org/10.1167/tvst.13.12.35

ARVO Annual Meeting Abstract June 2024

Anti-vascular endothelial growth factor (anti-VEGF) biosimilars in people with neovascular AMD (nAMD) – a systematic review and meta-analysis

Sueko Ng; Tomiko Sunaga; Masayuki Maeda; Rosella Saulle; Miki Takenaka Sato; Takeshi Hasegawa; Andrew Mason; Hisashi Noma; Erika Ota

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):223.

ARVO Annual Meeting Abstract June 2024

Changes in Aqueous Angiopoietin Concentrations during the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular Edema

Masahiko Shimura; Shotaro Sasaki; Ryota Nonaka; Kanako Yasuda; Hidetaka Noma

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6212.

ARVO Annual Meeting Abstract June 2023

Stable production of hESC/iPSC-derived retinal progenitor spheroid for cell-based therapies using label-free ghost cytometry sorting

Yasuaki Iwama; Tomohiro Masuda; Hiroko Nomaru; Yoko Kawamura; Yuri Murata; Kohji Nishida; Michiko Mandai

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3691.

ARVO Annual Meeting Abstract June 2022

Transcriptomic and metabolomic analyses of Fuchs endothelial corneal dystrophy and bullous keratopathy

Takefumi Yamaguchi; Yukari Yagi-Yaguchi; Takanori Suzuki; Hirotsugu Kasamatsu; Kazunari Higa; Masahiro Sugimoto; Hisashi Noma; Jun Shimazaki

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2279.

ARVO Annual Meeting Abstract July 2019

Change of Cytokines in Recurred Patients After Ranibizumab Therapy for Branch Retinal Vein Occlusion With Macular Edema

Hidetaka Noma; Kanako Yasuda; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4088.

ARVO Annual Meeting Abstract July 2018

Dynamics of inflammatory factors in aqueous humor under Ranibizumab or Aflibercept treatment for age-related macular degeneration

Ryosuke Motohashi; Hidetaka Noma; Kanako Yasuda; Osamu Kotake; Hiroshi Goto; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):62.

ARVO Annual Meeting Abstract July 2018

Anti-vascular endothelial growth factor agents reduce inflammation in central retinal vein occlusion with macular edema

Hidetaka Noma; Kanako Yasuda; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):389.

ARVO Annual Meeting Abstract June 2017

MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium

Hidetaka Noma; Kevin McDonald; Masahiko Shimura; Shigeo Tamiya

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):598.

ARVO Annual Meeting Abstract June 2017

Production and characterization of a sustained release system of dasatinib to prevent proliferative vitreoretinopathy

Shigeo Tamiya; Rajat Chauhan; Rayeanne Balgemann; Hidetaka Noma; Kevin McDonald; Henry J Kaplan; Martin O'Toole

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4759.

ARVO Annual Meeting Abstract September 2016

Vitreous concentrations of VEGF family indicate visual prognosis after vitrectomy in patients with rhegmatogenous retinal detachment

Masahiko Shimura; Ryosuke Motohashi; Kanako Yasuda; Hidetaka Noma

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1028.

ARVO Annual Meeting Abstract September 2016

Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Diabetic Macular Edema

Hidetaka Noma; Kanako Yasuda; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3245.

Glaucoma August 2015

Comparison of Longitudinal Changes in Functional and Structural Measures for Evaluating Progression of Glaucomatous Optic Neuropathy

PDF

Kenji Suda; Masanori Hangai; Tadamichi Akagi; Hisashi Noma; Yugo Kimura; Tomoko Hasegawa; Hiroshi Yamada; Munemitsu Yoshikawa; Hideo Nakanishi; Hanako Ohashi Ikeda; Nagahisa Yoshimura
TAGS: glaucoma, optic nerve disorders, eye, diagnostic imaging
Invest. Ophthalmol. Vis. Sci.. 2015; 56(9):5477-5484. https://doi.org/10.1167/iovs.15-16704

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

Change of Cytokines in Recurred Patients After Injection of Intravitreal Ranibizumab for Branch Retinal Vein Occlusion With Macular Edema

Hidetaka Noma; Kanako Yasuda; Hayate Nakagawa; Ryosuke Motohashi; Osamu Kotake; Hiroshi Goto; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):383.

ARVO Annual Meeting Abstract June 2015

Dynamic change of aqueous concentrations of cytokines and their receptors during the clinical course of ranibizumab treatment in diabetic macular edema.

Masahiko Shimura; Kanako Yasuda; Osamu Kotake; Ryosuke Motohashi; Hayate Nakagawa; Hidetaka Noma

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):4702.

Retina February 2015

Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Central Retinal Vein Occlusion With Macular Edema

PDF

Hidetaka Noma; Tatsuya Mimura; Kanako Yasuda; Masahiko Shimura
TAGS: central retinal vein occlusion, cytokine, edema, ligands, vascular endothelial growth factor a, vascular endothelial growth factor receptors, signal transduction, monocyte chemoattractant protein-1, interleukin-8, interleukin-6
Invest. Ophthalmol. Vis. Sci.. 2015; 56(2):1122-1128. https://doi.org/10.1167/iovs.14-15789

Retina June 2014

Role of Soluble Vascular Endothelial Growth Factor Receptors-1 and -2, Their Ligands, and Other Factors in Branch Retinal Vein Occlusion With Macular Edema

PDF

Hidetaka Noma; Tatsuya Mimura; Kanako Yasuda; Masahiko Shimura
TAGS: edema, ligands, vascular endothelial growth factor a, venous retinal branch occlusion, cytokine, placenta growth factor, interleukin-8, platelet-derived growth factor, aqueous humor, monocyte chemoattractant protein-1
Invest. Ophthalmol. Vis. Sci.. 2014; 55(6):3878-3885. https://doi.org/10.1167/iovs.14-13961

ARVO Annual Meeting Abstract April 2014

Changes of arterial and venous blood flow velocities at retinal vessel bifurcations

Masahiko Shimura; Sho Watarai; Tomoe Kanemaki; Akemi Ofusa; Nagisa Kojima; Teruumi Minezaki; Kanako Yasuda; Hidetaka Noma

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):4333.

ARVO Annual Meeting Abstract April 2014

Dynamic change of aqueous concentrations of VEGF and its soluble receptors during the treatment of aflibercept in patients with age-related macular degeneration

Akina Tanaka; Hidetaka Noma; Ryosuke Motohashi; Teruumi Minezaki; Kanako Yasuda; Masahiko Shimura

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):595.

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

OCT-derived tissue scatterer density and ganglion-cell-related layer thicknesses to assess physiological aging and glaucomatous changes

Changes in Aqueous Angiopoietin-1/2 Concentrations During the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular Edema

Anti-vascular endothelial growth factor (anti-VEGF) biosimilars in people with neovascular AMD (nAMD) – a systematic review and meta-analysis

Changes in Aqueous Angiopoietin Concentrations during the Induction Phase of Intravitreal Faricimab Injections for Diabetic Macular Edema

Stable production of hESC/iPSC-derived retinal progenitor spheroid for cell-based therapies using label-free ghost cytometry sorting

Transcriptomic and metabolomic analyses of Fuchs endothelial corneal dystrophy and bullous keratopathy

Change of Cytokines in Recurred Patients After Ranibizumab Therapy for Branch Retinal Vein Occlusion With Macular Edema

Dynamics of inflammatory factors in aqueous humor under Ranibizumab or Aflibercept treatment for age-related macular degeneration

Anti-vascular endothelial growth factor agents reduce inflammation in central retinal vein occlusion with macular edema

MCP-1 disrupts morphologic and functional barrier properties of polarized retinal pigment epithelium

Production and characterization of a sustained release system of dasatinib to prevent proliferative vitreoretinopathy

Vitreous concentrations of VEGF family indicate visual prognosis after vitrectomy in patients with rhegmatogenous retinal detachment

Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Diabetic Macular Edema

Comparison of Longitudinal Changes in Functional and Structural Measures for Evaluating Progression of Glaucomatous Optic Neuropathy

Change of Cytokines in Recurred Patients After Injection of Intravitreal Ranibizumab for Branch Retinal Vein Occlusion With Macular Edema

Dynamic change of aqueous concentrations of cytokines and their receptors during the clinical course of ranibizumab treatment in diabetic macular edema.

Role of Soluble Vascular Endothelial Growth Factor Receptor Signaling and Other Factors or Cytokines in Central Retinal Vein Occlusion With Macular Edema

Role of Soluble Vascular Endothelial Growth Factor Receptors-1 and -2, Their Ligands, and Other Factors in Branch Retinal Vein Occlusion With Macular Edema

Changes of arterial and venous blood flow velocities at retinal vessel bifurcations

Dynamic change of aqueous concentrations of VEGF and its soluble receptors during the treatment of aflibercept in patients with age-related macular degeneration

To View More...

You must be signed into an individual account to use this feature.